	Metaheuristic optimization of deep CNNs for multi-class diagnosis of cervical cancer and lymphoma. Sci Rep Abdelhay EH, Elgamily KM, Badr WOE. PMID: 42129228 [PubMed - indexed for MEDLINE]
	Germline DDX41 mutations in myeloid neoplasms: a comprehensive review. Korean J Intern Med Lee JH, Hur EH, Cho YU. PMID: 42128380 [PubMed - indexed for MEDLINE]
	Prognostic value of radionics based on 18F-FDG PET/CT in Hodgkin lymphoma: a systematic review. Rev Esp Med Nucl Imagen Mol (Engl Ed) Pradère C, Rasilla JM, Matilla BN, Soares PMM, Díaz KV, Solesio IG, Gallardo AG, Caballero MDPE, Casanovas MM. PMID: 42128173 [PubMed - as supplied by publisher]
	Development and evaluation of a systematic educational intervention for cutaneous lymphoma patients: A pilot study. Patient Educ Couns Moody W, Mott SL, Abid R, Mou E, Liu V. PMID: 42127710 [PubMed - as supplied by publisher]
	Erratum: Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial. J Clin Oncol Leonard JP, Trn, Zhang H, Nowakowski GS, Izutsu K, Fowler N, Thieblemont C, Zinzani PL, Gkasiamis A, Ahn JR, Gribben JG, AUGMENT Trial Investigators. PMID: 42127332 [PubMed - as supplied by publisher]
	Blinatumomab Consolidation for High-Risk Ph-negative B-cell Acute Lymphoblastic Leukemia: the GRAALL-2014/B-QUEST Study. Blood Boissel N, Huguet F, Leguay TT, Hunault M, Kim R, Hicheri Y, Passet M, Chevallier P, Balsat M, Pastoret C, Delabesse E, Maury S, Thiebaut-Bertrand A, Van Obbergh F, Cluzeau T, Escoffre M, Straetmans N, Konopacki J, Belhabri A, Villate A, Pasquier F, Vaida I, Sanhes L, Blum S, Alexis M, Lamarque M, Farnault L, Berthon C, Lheritier V, Ifrah N, Graux C, Chalandon Y, Clappier E, Dombret H. PMID: 42126414 [PubMed - as supplied by publisher]
	Effects of HPgV-1 Infections on Clinical Outcomes in Patients With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study. Clin Transplant Li Z, Li Y, Chen S. PMID: 42126392 [PubMed - indexed for MEDLINE]
	Flow cytometric analysis of phenotypes and naÃ¯ve/memory/effector T-cell subsets of T-cell large granular lymphocytic leukemia. Leuk Lymphoma Shao H, Dong N, Shao R, Sokol L, Zhang L. PMID: 42126107 [PubMed - as supplied by publisher]
	Defibrotide-Responsive Cutaneous Endothelial Injury Following Allogeneic Hematopoietic Stem Cell Transplant: A Case Report. Exp Clin Transplant Aslan Candir B, Ulu Uncu B, Citlak K, Atakul E, Altuntas F. PMID: 42126041 [PubMed - indexed for MEDLINE]
	Prognostic Significance of miR-181a and miR-181b Expression and NPM1 Mutations in Patients With Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplant. Exp Clin Transplant Saadi MI, Noshadi N, Ramzi M, Karimi Z, Yaghobi R, Parand S. PMID: 42126039 [PubMed - indexed for MEDLINE]
	Comparing a treatment combination that includes brentuximab vedotin with standard of care chemotherapy for treating advanced Hodgkin lymphoma: a plain language summary of the HD21 clinical study intended for patients and carers. Future Oncol Ferdinandus J, Buettner M, Stavliotis J, Behringer K, Hertzberg M, Kaul H, Borchmann P. PMID: 42126020 [PubMed - as supplied by publisher]
	PD-L1-armored CD19/CD22 dual-targeted CAR-T cell co-infusion bridging to allogeneic hematopoietic stem cell transplantation achieves 7-year sustained remission in an adult patient with early relapsed, chemorefractory B-cell acute lymphoblastic leukemia: a case report. Front Immunol Hua H, Wen S, Han X, Liu X, Zhou Z, Song Z, Zhang X, Wang F. PMID: 42125659 [PubMed - indexed for MEDLINE]
	RCLARITY: A Prospective Phase II Study of Rituximab Combined With Lenalidomide and Chidamide (RLC) for the Treatment of Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma. Am J Hematol Li C, Lei T, Xu X, Lu J, Zhu X, Chen Z, Weng X, Yu H, Chen X, Peng S, Han S, Yang H. PMID: 42124356 [PubMed - as supplied by publisher]
	The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational Opportunities. Nutrients Caserta S, Martino EA, Skafi M, Vigna E, Bruzzese A, Amodio N, Fiorillo M, Lucia E, D'Arrigo G, Olivito V, Labanca C, Mendicino F, Alvaro ME, Tripepi G, Morabito F, Gentile M. PMID: 42124002 [PubMed - indexed for MEDLINE]
	Analysis of Clinical Impact of CD33 rs12459419 Single-Nucleotide Polymorphism in AML Treated with Intensive Chemotherapy Without Gemtuzumab Ozogamicin. Int J Mol Sci Helfenstein S, Shaforostova I, Seipel K, Kronig MN, Legros M, Bacher U, Pabst T. PMID: 42123630 [PubMed - indexed for MEDLINE]
	Hematopoietic Aging and Leukemia: Mechanistic and Therapeutic Insights. Int J Mol Sci Li Z, Zhang H, Cheng N, Li H, Wang X, Shao J. PMID: 42123622 [PubMed - indexed for MEDLINE]
	Molecular Profiling of Acute Myeloid Leukemia in Pakistan: Comprehensive Variant Landscape Revealed by Targeted NGS. Int J Mol Sci Mahmood R, Khan SA, Ali S, Sharif F, Khurshid U, Ahmed D, Shahzad E, Malik HS, Asif N, Jahangir S. PMID: 42123510 [PubMed - indexed for MEDLINE]
	Differential Expression and Target Gene Analysis of PBMC-Derived microRNAs as Prognostic Biomarkers in Acute Lymphoblastic Leukemia. Int J Mol Sci Basingab FS, Alahdal H, Alwadaani D, Almuneef G, Barefah AS, Algiraigri AH, Hammad R, Elnakeeb M, Alrahimi JS, Zaher KA, Aldahlawi AM. PMID: 42123456 [PubMed - indexed for MEDLINE]
	SRC as a Prognostic and Immunomodulatory Biomarker in Acute Myeloid Leukemia: A Multi-Omics Study. Int J Mol Sci Zhong J, Liu X, Gu X, Liu Z. PMID: 42123320 [PubMed - indexed for MEDLINE]
	Advancing Immunotherapy in Chronic Lymphocytic Leukemia. Int J Mol Sci Bieli, Wysocka A, Tyrna D, Robak T, Pu. PMID: 42123307 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 167679

Page 1 of 8384



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy